Donald G Blair

Title: The Innovative Contributions of Donald G. Blair

Introduction

Donald G. Blair is a notable inventor based in Kensington, MD (US). He has made significant contributions to the field of genetics, particularly through his work on the ETS2 repressor factor (ERF). With a total of 5 patents, his innovations have the potential to impact cancer research and treatment.

Latest Patents

Among his latest patents, the invention related to the ETS2 repressor factor (ERF) stands out. This invention pertains to the ERF gene and the products encoded by this gene. More specifically, it involves DNA sequences encoding ERF and AERF, polypeptides encoded by such DNA sequences, and ERF chimeric molecules. The methods of using ERF and ERF chimeric molecules aim to reduce tumorigenicity in tumor cells. Another patent focuses on the ETS2 repressor factor (ERF) genetic locus and its products, reiterating the importance of the ERF gene in cancer research.

Career Highlights

Donald G. Blair has worked with esteemed organizations, including the United States of America as represented by the Department of Health. His work has contributed to advancements in genetic research and therapeutic applications.

Collaborations

Throughout his career, Donald has collaborated with notable colleagues such as George J. Mavrothalassitis and Robert J. Fisher. These collaborations have further enriched his research and innovations.

Conclusion

Donald G. Blair's contributions to the field of genetics, particularly through his patents related to the ETS2 repressor factor, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and research.